Critical Care · 2013 · 61 citations · 22 references
Life SciencesImmunologyMolecular BiologyClinical ImmunologyMolecular ImmunologySepsisBiomarkers In SepsisFlow CytometryImmune MonitoringSepsis DiagnosisSepsis PathophysiologySepsis PrognosisBiomarker-based Sepsis DiagnosisBiomarker-based Sepsis PrognosticationFlow Cytometry ImmunophenotypingImmunosuppression After SepsisNosocomial SepsisQuantitative Pcr DetectionReal-time Polymerase Chain Reaction (Pcr)Sepsis Predictors
Abstract Introduction Reduced monocyte human leukocyte antigen (mHLA)-DR surface expression in the late phase of sepsis is postulated as a general biomarker of sepsis-induced immunosuppression and an independent predictor of nosocomial infections. However, traditional monitoring of mHLA-DR by flow cytometry has disadvantages due to specific laboratory requirements. An mRNA-based HLA-DR monitoring by polymerase chain reaction (PCR) would improve the clinical usage and facilitate conduction of large multicenter studies. In this study, we evaluated an mRNA-based HLA-DR monitoring by quantitative real-time PCR (qRT-PCR) as an alternative method to traditional flow cytometry. Methods Fifty-nine patients with sepsis and blood culture growing pathogenic bacteria were studied. Blood samples were collected at day 1 or 2 after admission, for measurement of mHLA-DR by flow cytometry and mRNA expression of HLA-DRA and class II transactivator (CIITA) by qRT-PCR. Blood samples from blood donors were used as controls (n = 30). Results A significant reduced expression of mHLA-DR, HLA-DRA, and CIITA was seen in septic patients compared with controls . HLA-DRA mRNA level in whole blood was highly correlated with surface expression of mHLA-DR. Conclusions Patients with sepsis display a diminished expression of HLA-DR at the monocyte surface as well as in the gene expression at the mRNA level. The mRNA expression level of HLA-DRA monitored by qRT-PCR correlates highly with surface expression of HLA-DR and appears to be a possible future biomarker for evaluation of immunosuppression in sepsis.
22
R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes et al. · Critical Care Medicine · 2013 · 9.7K citations
Veterinary Medicine, Infectious Diseases, Internal Medicine +9
Hydrocortisone Therapy for Patients with Septic Shock
Charles L. Sprung, Djillali Annane, Didier Keh et al. · New England Journal of Medicine · 2008 · 2.1K citations · Full text
Medicine, Pharmacotherapy, Critical Care Pharmacotherapy +14
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Jonathan Boomer, Kathleen To, Kathy Chang et al. · JAMA · 2011 · 1.7K citations · Full text